In this fourth session of the Building Bridges Across the Laboratory Community series, ASCP, and CDC are excited to bring you a case study featuring Suzanne Dale, PhD, D(ABMM) on how the Labcorp team worked closely with the CDC and FDA to validate and scale high-throughput testing platforms to response to the emergence of mpox during the summer of 2022. Reference labs are uniquely suited to rapidly increase testing capacity and access to laboratory testing to support public health responses. In addition, the large amount of data generated from high-throughput testing for infectious diseases can provide real-time insights on the epidemiology of outbreaks. Dr. Dale will share her experience collaborating with the CDC and the FDA to validate and scale laboratory assays for mpox, as well as insights from the laboratory data generated from offering testing nationally.

Faculty

Suzanne E. Dale, PhD, D(ABMM)
Discipline Director; Molecular Microbiology and Molecular Infectious Diseases, Labcorp